Genetics and epigenetics of renal cell cancer (Q37054515)

18 August 2017

title

Genetics and epigenetics of renal cell cancer (English)

1 reference

18 August 2017

1 reference

6

Manon van Engeland

1 reference

18 August 2017

author name string

Marcella M L Baldewijns

1

1 reference

18 August 2017

Iris J H van Vlodrop

2

1 reference

18 August 2017

Leo J Schouten

3

1 reference

18 August 2017

Patricia M M B Soetekouw

4

1 reference

18 August 2017

Adriaan P de Bruïne

5

1 reference

18 August 2017

publication date

15 December 2007

1 reference

Biochimica et Biophysica Acta

18 August 2017

language of work or name

English

0 references

published in

1 reference

18 August 2017

volume

1785

1 reference

18 August 2017

issue

2

1 reference

18 August 2017

page(s)

133-155

1 reference

publication type of scholarly work

18 August 2017

review article

1 reference

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/20459

Mutations of the VHL tumour suppressor gene in renal carcinoma

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/NG0594-85

Comparing the DNA hypermethylome with gene mutations in human colorectal cancer

2 references

https://opencitations.net/index/api/v1/citations/10.1371/JOURNAL.PGEN.0030157

1 March 2026

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

The genetics and genomics of cancer

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

The von Hippel-Lindau tumor suppressor gene

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Multilocular cystic renal cell carcinoma

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Targeting HIF-1 for cancer therapy

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Intragenic PTEN/MMAC1 loss of heterozygosity in conventional (clear-cell) renal cell carcinoma is associated with poor patient prognosis

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

1 March 2026

Hereditary renal cancers

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Sarcomatoid renal cell carcinoma: biologic behavior, prognosis, and response to combined surgical resection and immunotherapy

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Promoter hypermethylation profile of kidney cancer with new proapoptotic p53 target genes and clinical implications

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

The Sema domain of Met is necessary for receptor dimerization and activation

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

1 March 2026

The mammalian epigenome

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Gene methylation and early detection of genitourinary cancer: the road ahead

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Use of analgesics and risk of renal cell cancer

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

The von Hippel-Lindau tumor suppressor gene and kidney cancer

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Kidney cancer: identification of novel targets for therapy

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Does diuretic therapy increase the risk of renal cell carcinoma?

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Is there an association between hypertension and cancer mortality?

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Multilocular cystic renal cell carcinoma: an experience of clinical management for 31 cases

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Microscopic vascular invasion is the most relevant prognosticator after radical nephrectomy for clinically nonmetastatic renal cell carcinoma

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Genetic basis of cancer of the kidney: disease-specific approaches to therapy.

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Appraisal of intratumoral microvessel density, MIB-1 score, DNA content, and p53 protein expression as prognostic indicators in patients with locally confined renal cell carcinoma

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Using protein expressions to predict survival in clear cell renal carcinoma

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Genetic and epigenetic alterations in the von hippel-lindau gene: the influence on renal cancer prognosis.

1 March 2026

2 references

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

1 March 2026

https://opencitations.net/index/api/v1/citations/10.1158/1078-0432.CCR-07-1753

Oxidative stress and DNA hypermethylation status in renal cell carcinoma arising in patients on dialysis

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

A novel entity: low-grade mucinous tubular renal carcinoma

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Hsp90 inhibitors as novel cancer chemotherapeutic agents

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Improved prognostication of renal cell carcinoma using an integrated staging system

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Alcohol intake and renal cell cancer in a pooled analysis of 12 prospective studies

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC)

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma.

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Recombinant alfa interferon in renal cell carcinoma: a randomized trial of two routes of administration

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Histone deacetylase inhibitor and demethylating agent chromatin compaction and the radiation response by cancer cells

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Risk factors for renal-cell cancer in Shanghai, China

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Overweight as an avoidable cause of cancer in Europe

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Prevalence of tuberous sclerosis estimated by capture-recapture analysis.

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Birt-Hogg-Dubé syndrome: a novel marker of kidney neoplasia

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Acquired renal cystic disease: implications for the urologist

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Risk factors for renal cell carcinoma: results of a population-based case-control study

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

VHL expression in renal cell carcinoma sensitizes to bortezomib (PS-341) through an NF-kappaB-dependent mechanism.

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Risk factors for adult renal cell carcinoma: a systematic review and implications for prevention.

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Genetic basis of cancer of the kidney

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Surgical management of renal cell carcinoma

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Interleukin-2 therapy of metastatic renal cell carcinoma--predictors of response

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Sorafenib in advanced clear-cell renal-cell carcinoma

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Renal Cell Carcinoma Recurrence After Nephrectomy for Localized Disease: Predicting Survival From Time of Recurrence

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Optimal primer design using the novel primer design program: MSPprimer provides accurate methylation analysis of the ATM promoter.

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Scoring algorithm to predict survival after nephrectomy and immunotherapy in patients with metastatic renal cell carcinoma: a stratification tool for prospective clinical trials

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Epigenetic inactivation of the candidate tumor suppressor gene HOXB13 in human renal cell carcinoma

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

The fundamental role of epigenetic events in cancer

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

SLIT2 promoter methylation analysis in neuroblastoma, Wilms' tumour and renal cell carcinoma

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Mechanism of von Hippel-Lindau protein-mediated suppression of nuclear factor kappa B activity

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Aberrant methylation of the 8p22 tumor suppressor gene DLC1 in renal cell carcinoma.

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Trichloroethylene exposure and specific somatic mutations in patients with renal cell carcinoma

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1 alpha-degradative pathway

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Bellini duct carcinoma: further evidence for this rare variant of renal cell carcinoma

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Searching for the hereditary causes of renal-cell carcinoma

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Methylation-specific PCR unraveled

1 March 2026

2 references

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

1 March 2026

https://opencitations.net/index/api/v1/citations/10.1155/2004/370301

Role of VHL gene mutation in human cancer

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Chromophobe Cell Renal Carcinoma: Clinicopathological Features of 50 Cases

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d'Immunothérapie

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

von Hippel-Lindau disease affecting 43 members of a single kindred

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

A case-control study of diet and risk of renal adenocarcinoma.

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease.

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Prognostic significance of multidrug-resistance protein (MDR-1) in renal clear cell carcinomas: a five year follow-up analysis.

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Vaccines in renal cell carcinoma

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Paraneoplastic Signs and Symptoms of Renal Cell Carcinoma: Implications for Prognosis

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

International renal-cell cancer study. II. Analgesics

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Regulation of histone methylation by demethylimination and demethylation

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Promoter hypermethylation profile of kidney cancer

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

The role of chromatin during transcription

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Hypoxia-inducible factors: central regulators of the tumor phenotype

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Identification of novel target genes by an epigenetic reactivation screen of renal cancer

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Prognostic factors in metastatic renal carcinoma

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Renal cell carcinoma, a new complication of analgesic nephropathy

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Nephrectomy Followed by Interferon Alfa-2b Compared with Interferon Alfa-2b Alone for Metastatic Renal-Cell Cancer

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Multilocular cystic renal cell carcinoma: a series of 12 cases and review of the literature

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Targeted inactivation of fh1 causes proliferative renal cyst development and activation of the hypoxia pathway

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Diet and vitamin or mineral supplements and risk of renal cell carcinoma in Canada

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Renal medullary carcinoma: clinical, pathologic, immunohistochemical, and genetic analysis with pathogenetic implications

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Increased nuclear factor-kappa B activation is related to the tumor development of renal cell carcinoma

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

The Heidelberg classification of renal cell tumours

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Nutrition and renal cell cancer

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

A case-control study of renal cell carcinoma in relation to occupation, smoking, and alcohol consumption

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

High expression levels of survivin protein independently predict a poor outcome for patients who undergo surgery for clear cell renal cell carcinoma

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Risk factors for renal-cell carcinoma in a French case-control study

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Hereditary Multiple Fibrofolliculomas With Trichodiscomas and Acrochordons

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significance

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Role of carbonic anhydrases in the progression of renal cell carcinoma subtypes: proposal of a unified hypothesis

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Papillary renal tumors. Morphologic, cytochemical, and genotypic features

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Global increases in kidney cancer incidence, 1973-1992.

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Validation and extension of the Memorial Sloan-Kettering prognostic factors model for survival in patients with previously untreated metastatic renal cell carcinoma

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Cystic renal cell carcinoma is cured by resection: a study of 24 cases with long-term followup

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Comprehensive mutational analysis of the VHL gene in sporadic renal cell carcinoma: relationship to clinicopathological parameters

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Renal cell carcinoma in relation to cigarette smoking: Meta-analysis of 24 studies

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

1 March 2026

Incidental renal tumors

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

The necessity of a human epigenome project

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Cancer as a manifestation of aberrant chromatin structure

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Prevalence of von Hippel-Lindau gene mutations in sporadic renal cell carcinoma: results from The Netherlands cohort study

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Unexplained spontaneous regression and alpha-interferon as treatment for metastatic renal carcinoma

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

The t(1;3) breakpoint-spanning genes LSAMP and NORE1 are involved in clear cell renal cell carcinomas

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Oncogenic mechanisms mediated by DNA methylation

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Constitutive activation of nuclear factor-kappaB prevents TRAIL-induced apoptosis in renal cancer cells

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Major dietary patterns and risk of renal cell carcinoma in a prospective cohort of Swedish women

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

VASCULAR ENDOTHELIAL GROWTH FACTOR AS PROGNOSTIC FACTOR IN RENAL CELL CARCINOMA

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Identification of the von Hippel-Lindau disease tumor suppressor gene

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

A second major native von Hippel-Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor.

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Demethylating agent 5-aza-2'-deoxycytidine enhances susceptibility of renal cell carcinoma to paclitaxel

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Hypermethylation of the CpG island of theRASSF1A gene in ovarian and renal cell carcinomas

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin.

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Chromatin modifications and their function

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Alternate choice of initiation codon produces a biologically active product of the von Hippel Lindau gene with tumor suppressor activity

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Alcohol drinking and renal cell carcinoma in women and men

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Cancer epigenomics: DNA methylomes and histone-modification maps

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Alterations in DNA Methylation: A Fundamental Aspect of Neoplasia

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Malignant renal tumors in tuberous sclerosis

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Lack of mutation of the folliculin gene in sporadic chromophobe renal cell carcinoma and renal oncocytoma

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

PRCC-TFE3 renal carcinomas: morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21).

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, single institution cohort

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Renal cell carcinoma: current status and future prospects

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Clinical significance of lymph node dissection in renal cell carcinoma

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Studying cancer families to identify kidney cancer genes

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

The evolving presentation of renal carcinoma in the United States: trends from the Surveillance, Epidemiology, and End Results program

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Analysis of the Birt-Hogg-Dubé (BHD) tumour suppressor gene in sporadic renal cell carcinoma and colorectal cancer

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Mechanisms of disease: hereditary leiomyomatosis and renal cell cancer--a distinct form of hereditary kidney cancer

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

The tuberous sclerosis complex genes in tumor development

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Wilms' tumour in adults: a case report and review of the literature.

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Gender, alcohol consumption, and renal cell carcinoma

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Loss of heterozygosity and methylation of p16 in renal cell carcinoma

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Expression of Birt-Hogg-Dubé gene mRNA in normal and neoplastic human tissues

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

A germline insertion in the tuberous sclerosis (Tsc2) gene gives rise to the Eker rat model of dominantly inherited cancer

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

The JMJD2 members of histone demethylase revisited.

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Bilateral renal cell carcinoma in the Birt-Hogg-Dubé syndrome

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Quantitative promoter methylation analysis of multiple cancer-related genes in renal cell tumors

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

The changing natural history of renal cell carcinoma

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Epidemiology of renal cell carcinoma

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

pVHL 19 is a biologically active product of the von Hippel–Lindau gene arising from internal translation initiation

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Hypermethylation of the DNA repair gene O(6)-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Poor prognosis associated with thrombocytosis in patients with renal cell carcinoma

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

RASSF1A promoter methylation and expression analysis in normal and neoplastic kidney indicates a role in early tumorigenesis

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

The emerging science of epigenomics

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Analysis of the TSC1 and TSC2 genes in sporadic renal cell carcinomas.

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Tuberous sclerosis and the kidney: from mesenchyme to epithelium, and beyond

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Regional lymph node dissection in the treatment of renal cell carcinoma: is it useful in patients with no suspected adenopathy before or during surgery?

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

DNA hypomethylation and human diseases.

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

The cancer epigenome--components and functional correlates

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Met decoys: will cancer take the bait?

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

The von Hippel-Lindau tumor suppressor protein and clear cell renal carcinoma

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

VHL mutations in renal cell cancer: does occupational exposure to trichloroethylene make a difference?

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

An epidemiological study of renal pathology in tuberous sclerosis complex

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Gene expression and promoter methylation of the XIAP-associated Factor 1 in renal cell carcinomas: correlations with pathology and outcome

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Novel mutations of the MET proto-oncogene in papillary renal carcinomas.

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

International renal‐cell cancer study. VIII. Role of diuretics, other anti‐hypertensive medications and hypertension

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Evaluation of dietary, medical and lifestyle risk factors for incident kidney cancer in postmenopausal women.

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Prognostic significance of morphologic parameters in renal cell carcinoma.

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

A histone H3 lysine 27 demethylase regulates animal posterior development

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Gene silencing in cancer in association with promoter hypermethylation

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Promoter CpG hypermethylation and downregulation of XAF1 expression in human urogenital malignancies: implication for attenuated p53 response to apoptotic stresses

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Role of the Ras-association domain family 1 tumor suppressor gene in human cancers

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Multigene methylation analysis of Wilms' tumour and adult renal cell carcinoma

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Promoter hypermethylation of the potential tumor suppressor DAL-1/4.1B gene in renal clear cell carcinoma

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Hereditary papillary renal cell carcinoma

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

Treatment of early non-small cell lung cancer, stage IA, by image-guided robotic stereotactic radioablation--CyberKnife

1 March 2026

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.BBCAN.2007.12.002

10.1016/J.BBCAN.2007.12.002

2 March 2026

Identifiers

DOI

1 reference

18 August 2017

1 reference